MENU

MDNA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Medicenna Therapeutics (MDNA) Ownership - Who owns Medicenna Therapeutics?

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

2 Bloor Street W.

Phone

+1 416 648-5555

Employees

16

Web

https://www.medicenna.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

12.54M

P/E Ratio

N/A

Total Cash

29.62M

Projected Growth

N/A

Total Debt

N/A

Revenue

N/A

Risk (Beta)

0.83

Dividend Yield

N/A

Total Cash/Share

0.43

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MDNA

A.I. Advisor

published General Information

General Information

a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers

Industry Biotechnology

Profile

Details

Industry

N/A

Address

2 Bloor Street W.

Phone

+1 416 648-5555

Employees

16

Web

https://www.medicenna.com